Loading clinical trials...

Emerging Adults Who Use Alcohol and Marijuana | Clinical Trials | Clareo Health

COMPLETEDPHASE3

Emerging Adults Who Use Alcohol and Marijuana

Reducing STIs in Emerging Adults Who Use Alcohol and Marijuana

NCT01473719•Butler Hospital

Summary

The purpose of this study is to if a brief motivational intervention, compared to health education sessions, reduces alcohol and marijuana use and is related to fewer sexually transmitted infections (STI)in emerging adults who are engaging in alcohol and marijuana use.

Eligibility

Age

18 - 25 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Be between the ages of 18 and 25
•Binge drink (5 or more drinks in a 2-hour period for men, 4 or more for women) at least monthly
•Use marijuana at least weekly
•Have been heterosexually active in the past six months
•Are not married
•Have not been living with a sexual or romantic partner for more than 6 months
•Be English speaking
•Reside within 20 miles of Providence, RI and plans to stay in the geographic area for the next 15 months
•Provide contact information for at least two verifiable locator persons

Exclusion Criteria

•Have DSM-IV diagnosis of drug abuse or dependence (other than nicotine, marijuana)
•Have DSM-IV diagnosis of alcohol dependence

Locations (1)

Butler Hospital

Providence, Rhode Island, United States

Key Dates

Start Date

January 1, 2012

Primary Completion Date

August 1, 2017

Completion Date

August 1, 2017

Last Updated

September 18, 2017

Enrollment

566

ACTUAL participants

Conditions

Alcohol UseMarijuana UseSexually Transmitted Infections

Interventions

motivational intervention

BEHAVIORAL

health education

BEHAVIORAL

Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment

NCT05855668

Alcohol Use DisorderCannabis Use Disorder

View study

RECRUITINGNA

Web-based Alcohol- or Cocaine-specific Inhibition Training in Adolescents and Young Adults With Substance Use Disorder

NCT07071779

Alcohol Use Disorder (AUD)Cocaine Use Disorder (CUD)+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 18, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Emerging Adults Who Use Alcohol and Marijuana

Inclusion Criteria

Exclusion Criteria

Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment

Web-based Alcohol- or Cocaine-specific Inhibition Training in Adolescents and Young Adults With Substance Use Disorder

Virtual Reality (VR) NATURE - Alcohol Use Disorder (AUD)

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

Anxiety During Abstinence in AUD

Image-guided, Robot Navigated Transcranial Magnetic Stimulation (IR-TMS) for Alcohol Use Disorder (AUD)